Law 360 M&A

APRIL 7, 2023

Stockholders of biopharmaceutical company Catalyst Biosciences Inc. have asked the Delaware Chancery Court to halt a scheduled stockholder vote until the company releases more information about its planned acquisition of a fibrosis drug from an Asia-based drug development company.

40

40

Law 360 M&A

JUNE 16, 2022

A Catalyst Biosciences Inc. stockholder group has sued the company's directors for selling all its viable assets and keeping investors in the dark about plans for the $60 million in proceeds, claiming in a Delaware Chancery Court suit the board repeatedly breached its fiduciary duty.

40

40

Benzinga

NOVEMBER 13, 2023

million from concurrent private financing; expected cash runway through Phase 3 development of Descartes-08 for MG – – Combined company to be led by Carsten Brunn, Ph.D.; million from concurrent private financing; expected cash runway through Phase 3 development of Descartes-08 for MG – – Combined company to be led by Carsten Brunn, Ph.D.;

Finance 40

Finance Technology 40